Patent ID: 8889866

Claim:
A compound of formula (I), including a stereochemically isomeric form thereof; wherein Y is CH 2 or CH 2 —CH 2 ; R 1 is aryl or Het; wherein aryl is phenyl or naphthalenyl; wherein Het is thienyl, pyrrolyl, pyrrolinyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, oxadiazolyl, triazolyl, tetrazolyl, thiadiazolyl, furanyl, piperidinyl, pyridinyl, pyridazinyl, pyrimidinyl, piperazinyl, pyrazinyl, triazinyl, indolizinyl, azaindolizinyl, indolyl, indolinyl, benzothienyl, indazolyl, benzoxazolyl, benzimidazolyl, benzofuranyl, benzothiazolyl, benzotriazolyl, chromanyl, purinyl, quinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxazolinyl, naphthyridinyl or pteridinyl; each aryl or Het can be substituted with one or two substituents each independently selected from halo, cyano C 1-6 alkyl C 1-6 alkyloxycarbonyl, —C 1-6 alkylNR 8 R 9 , and —OR 8 ; or R 1 is a radical of formula wherein X 1 is CH 2 , NH or N—CH 3 ; wherein X 2 is CH 2 , C═O, O, NH or N—CH 3 ; wherein R 10 is phenyl, pyridinyl, pyridazinyl or pyrimidinyl, wherein each phenyl, pyridinyl, pyridazinyl or pyrimidinyl can be substituted with one or two substituents each independently selected from halo, hydroxy, cyano, C 1-6 alkyl, amino, polyhaloC 1-6 alkyl or C 1-6 alkyloxy; or R 1 is a radical of formula wherein X 3 is CH or N; R 2 is methyl, ethyl, propyl or C 3-6 cycloalkyl; each R 3 and R 4 is hydrogen; each R 5 , R 6 , and R 7 is hydrogen; each R 8 and R 9 is independently selected from hydrogen, halo, C 1-6 alkyl, or trihaloC 1-6 alkyl; a N-oxide form thereof, a pharmaceutically acceptable addition salt thereof or a solvate thereof.